RAPT Therapeutics, Inc. Total Liabilities
RAPT Therapeutics, Inc. had Total Liabilities of $13.76 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2025-11-06
- 2025-09-30: Liabilities $13.76M.
- 2025-06-30: Liabilities $14.00M.
- 2025-03-31: Liabilities $10.20M.
- 2024-12-31: Liabilities $50.42M.
| Period end | Liabilities |
|---|---|
| 2025-09-30 | $13.76M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $14.00M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $10.20M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $50.42M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $12.96M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $17.96M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $24.98M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $26.29M 10-K · filed 2025-03-06 |
| 2023-09-30 | $26.92M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $21.08M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $27.86M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $21.04M 10-K · filed 2024-03-07 |
| 2022-09-30 | $20.18M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $19.86M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $19.71M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $12.26M 10-K · filed 2023-03-14 |
| 2021-09-30 | $15.59M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $13.50M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $14.28M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $14.79M 10-K · filed 2022-03-10 |
| 2019-12-31 | $11.48M 10-K · filed 2021-03-11 |